James R. Johnson, MD - Minneapolis VA Health Care System
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Minneapolis VA Health Care System

Menu
Menu
Veterans Crisis Line Badge
My HealtheVet badge
EBenefits Badge
 

James R. Johnson, MD

Dr. James Johnson

Staff Physician, Minneapolis VA Healthcare System

Director, Molecular Epidemiology Unit, Minneapolis VA Health Care System

Professor, Medicine, University of Minnesota

Director, ID Fellowship Program and T32 Program, University of Minnesota

Telephone: 612-467-4188

Email: james.johnson1ca475@va.gov

 


Education

  • BA, Macalester College, St. Paul, MN
  • MD, University of Minnesota

Research Interests

  • Extraintestinal E. coli infections
  • Antimicrobial resistance
  • Enterococcus infections
  • Ecology, evolution, virulence

Selected Publications

  • Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 2014;52:1358-65. PMID: 24501035
  • Carl MA, Ndao M, Springman AC, Manning SD, Johnson JR, Johnston BD, Burnham C-AD, Weinstock ES, Weinstock GM, Wylie T, Mitreva M, Abubucker S, Zhou Y, Stevens H, Hall-Moore C, Julian S, Shaikh N, Warner BB, Tarr PI. Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infections. Clin Infect Dis 2014;58:1211-8. PMID: 24501035.
  • Leuck A-M, Johnson JR, Dunny GM. A widely used in vitro biofilm assay has questionable clinical significance for enterococcal endocarditis. PLoS One (in press).
  • Olesen B, Frimodt-Møller J, Leihof RF, Struve C, Johnston B, Hansen DS, Scheutz F, Krogfelt KA, Kuskowski MA, Clabots C, Johnson JR. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968-2012. Antimicrob Agents Chemother (in press).
  • Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots, C, Lautenbach E, Johnson JR (for the CDC Prevention Epicenters Program). Clinical and molecular epidemiology of Escherichia coli sequence type 131 (ST131) among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli. Antimicrob Agents Chemother (in press).
  • Liss MA, Johnson JR, Porter SB, Johnston B, Clabots C, Gillis K, Nseyo U, Holden M, Sakamoto K, Fierer J. Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis (in press).
  • Leuck A-M, Johnson JR, Hunt MA, Dhody K, Kazempour K, Ferrieri P, Kline S. Safety and efficacy of a novel silver-impregnated Foley catheter system for preventing catheter-associated bacteriuria: a pilot randomized clinical trial. AJIC (in press).
  • Mitchell NM, Johnson JR, Johnston B, Curtiss 3rd R, Mellata M. Genotypic and phenotypic assessment of the zoonotic potential of Escherichia coli isolates from retail poultry meat products and eggs. Appl Environ Microbiol (in press).

 

Back